Witruth Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Witruth Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Witruth Capital Today - Breaking & Trending Today

Week in review: Everest sells trodelvy rights back to Gilead for $455 million

Published: August 22, 2022

Everest Medicines returned rights for Trodelvy to Immunomedics. Nanchang Jemincare out-licensed global rights for its prostate cancer candidate to Genentech in a $650 million deal.

Source: seekingalpha.com

Related Topics:

New JerseyUnited StatesBennu BiotherapeuticsEquecabtagene AutoleucelLife Science Park Innovation FundGilead SciencesAutomatic Inspection MachineEverest MedicinesWitruth CapitalWyze BiotechAimmune TherapeuticsWuhan East Lake Venture CapitalNeuromyelitis Optica Spectrum DisorderCastration Resistant ProstateNew Jersey ShanghaiChina PhaseObjective Response Rate